Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.31USD
22 Mar 2019
Change (% chg)

$-0.15 (-6.10%)
Prev Close
$2.46
Open
$2.44
Day's High
$2.46
Day's Low
$2.26
Volume
23,980
Avg. Vol
30,302
52-wk High
$12.90
52-wk Low
$1.22

Chart for

About

Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $23.88
Shares Outstanding(Mil.): 13.92
Dividend: --
Yield (%): --

Financials

  CLRB.OQ Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -1.24 -- --
ROI: -103.68 14.23 13.82
ROE: -105.20 15.46 15.25

Earnings vs. Estimates